Clinical Trial Update: Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and protective efficacy of Bacillus Calmette-Guérin (BCG) vaccination against controlled human malaria infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Malaria, Plasmodium Falciparum | Phase 2 | Status: COMPLETED